Insider: Thorp Clay Director - Clearside Biomedical, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 176,141 | 3,433,521 | 3,609,662 |
| Value | $657,005.93 | $12,807,033.33 | $13,464,039.26 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/24/2025 | AAP | 15,000 | Direct | COM | $0.92 | $13,800.00 | 176,141 |
| 09/25/2023 | AAP | 10,000 | Direct | COM | $0.86 | $8,600.00 | 40,522 |
| 12/21/2022 | AAP | 14,000 | Direct | COM | $1.02 | $14,266.00 | 30,522 |
| 02/10/2021 | DDS | 32,873 | Indirect | COM | $4.43 | $145,627.39 | 3,433,521 |
| 12/06/2018 | AAP | 8,000 | Direct | COM | $1.36 | $10,880.00 | 8,000 |
| 05/18/2018 | DDS | 61,139 | Indirect | COM | $13.16 | $804,589.24 | 3,466,394 |
| 05/17/2018 | DDS | 100,000 | Indirect | COM | $13.03 | $1,303,000.00 | 3,527,533 |
| 03/23/2018 | DDS | 5,231 | Indirect | COM | $12.02 | $62,876.62 | 3,627,533 |
| 03/22/2018 | DDS | 33,630 | Indirect | COM | $12.07 | $405,914.10 | 3,632,764 |
| 03/21/2018 | DDS | 100,000 | Indirect | COM | $12.27 | $1,227,000.00 | 3,666,394 |
| 12/07/2017 | DDS | 5,000 | Indirect | COM | $6.13 | $30,650.00 | 3,766,394 |
| 12/06/2017 | DDS | 15,000 | Indirect | COM | $6.09 | $91,350.00 | 3,771,394 |
| 12/05/2017 | DDS | 15,000 | Indirect | COM | $6.37 | $95,550.00 | 3,786,394 |
| 11/16/2017 | DDS | 5,000 | Indirect | COM | $6.99 | $34,950.00 | 3,801,394 |
| 11/15/2017 | DDS | 15,000 | Indirect | COM | $6.99 | $104,850.00 | 3,806,394 |
| 11/14/2017 | DDS | 15,000 | Indirect | COM | $7.02 | $105,300.00 | 3,821,394 |
| 10/05/2017 | DDS | 6,000 | Indirect | COM | $8.34 | $50,040.00 | 3,836,394 |
| 10/04/2017 | DDS | 14,000 | Indirect | COM | $8.59 | $120,260.00 | 3,842,394 |
| 10/03/2017 | DDS | 15,000 | Indirect | COM | $8.64 | $129,600.00 | 3,856,394 |
| 09/15/2017 | DDS | 10,000 | Indirect | COM | $7.54 | $75,400.00 | 3,871,394 |
| 09/14/2017 | DDS | 6,000 | Indirect | COM | $7.52 | $45,120.00 | 3,881,394 |
| 09/13/2017 | DDS | 8,500 | Indirect | COM | $7.49 | $63,665.00 | 3,887,394 |
| 08/09/2017 | DDS | 15,000 | Indirect | COM | $7.30 | $109,500.00 | 3,895,894 |
| 08/08/2017 | DDS | 5,000 | Indirect | COM | $7.98 | $39,900.00 | 3,910,894 |
| 08/07/2017 | DDS | 4,500 | Indirect | COM | $8.02 | $36,090.00 | 3,915,894 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research